InvestorsHub Logo
Followers 11
Posts 1008
Boards Moderated 0
Alias Born 08/04/2016

Re: plexrec post# 456612

Sunday, 04/14/2024 11:27:53 AM

Sunday, April 14, 2024 11:27:53 AM

Post# of 458252
I agree with Frrol’s assessment:

“There's a lot of skepticism over our commercial prospects, and management credibility. The shares have sold down, which is a normal market reaction. Fortunately, these are not factors in the actual performance of our lead drug, which does appear to show efficacy signal. We are on an encouraging decision path for EMA assessment in AD.”

I think we get there and that Anavex is a compelling risk reward play even more so at current price levels. When there’s blood in the street….
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News